Eugene Kennedy
Direttore Tecnico/Scientifico/R&S presso CARISMA THERAPEUTICS, INC.
Patrimonio netto: - $ in data 30/04/2024
Profilo
Eugene P.
Kennedy is currently the Chief Medical Officer at Carisma Therapeutics, Inc. He previously held positions as an Associate Professor-Surgery at Thomas Jefferson University from 2006 to 2013, Vice President-Clinical & Medical Affairs at NewLink Genetics Corp.
from 2014 to 2017, and Chief Medical Officer at Lumos Pharma, Inc. from 2013 to 2021.
He also served as a Trustee at The Hope Funds for Cancer Research.
Additionally, he was the Chief Medical Officer at Innovative Cellular Therapeutics, Inc. and Galera Therapeutics, Inc. from 2022 to 2023.
Dr. Kennedy obtained his undergraduate degree from the University of Virginia and his doctorate from the Medical College of Virginia.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 25/02/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Posizioni attive di Eugene Kennedy
| Società | Posizione | Inizio |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 02/05/2024 |
Precedenti posizioni note di Eugene Kennedy
| Società | Posizione | Fine |
|---|---|---|
| GALERA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2023 |
| LUMOS PHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 06/03/2021 |
| Thomas Jefferson University | Corporate Officer/Principal | 01/12/2013 |
| Innovative Cellular Therapeutics, Inc. | Direttore Tecnico/Scientifico/R&S | - |
The Hope Funds for Cancer Research
 The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Direttore/Membro del Consiglio | - |
Formazione di Eugene Kennedy
| University of Virginia | Undergraduate Degree |
| Medical College of Virginia | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| GALERA THERAPEUTICS, INC. | Health Technology |
| LUMOS PHARMA, INC. | Health Technology |
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
The Hope Funds for Cancer Research
The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Commercial Services |
| Innovative Cellular Therapeutics, Inc. |
- Borsa valori
- Insiders
- Eugene Kennedy
